Therapy News and Research

RSS

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

GlaxoSmithKline plc and Boehringer Ingelheim announced today that both companies welcome the United States' continued involvement in the global response to HIV/AIDS.

17 May 2004

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

New international consensus guidelines for FUZEON (enfuvirtide) are published today in AIDS, the official journal of the International AIDS Society.

17 May 2004

Researchers demonstrate wearable electronics to aid health and fashion

Soon you may be wearing your computer, or elements of it, according to a team of researchers and designers at Arizona State University. The era of smart bodysuits is about to begin.

17 May 2004

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans to ensure that the thousands of HIV-infected people currently not receiving care through existing programs gain access to the services they need, says a new report from the Institute of Medicine of the National Academies.

16 May 2004

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Bristol-Myers Squibb Company, Gilead Sciences, Inc. and Merck & Co., Inc. have announced that they are in discussions on the development of a once-daily, fixed-dose combination of three anti-HIV drugs and are also considering certain co-packaging options for the individual products.

16 May 2004

Higher rate of cardiac complications from smallpox vaccinations for US military

While adverse reactions from smallpox vaccinations given to military personnel in the wake of renewed threats of bioterrorism remain minimal, the rate of cardiac complications has been higher than expected, according to a clinical review presented at an American Medical Society media briefing on cardiology today.

16 May 2004

Glucose metabolism could be used to selectively destroy cancer cells

Scientists have known for decades that cancer cells consume more glucose than normal cells. A longstanding assumption that the excess glucose metabolism was needed to make energy has not been borne out by research studies.

15 May 2004

Genetically engineered viruses may create new class of cancer therapies

A genetically engineered virus can selectively kill cancerous cells in the lung and colon while leaving healthy cells intact, according to new research published today in Cancer Research by William Wold and colleagues at Saint Louis University School of Medicine.

15 May 2004

Risk of artery plaques increased by use of HIV drugs

An Italian study has provided evidence that HIV drugs called protease inhibitors may increase the risk of artery "plaques."

15 May 2004

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

The idea is to use a modified form of HIV to deliver an "antisense" gene to the immune cells that HIV infects. This is integrated into the cells' genome, and stays there until a cell is infected. Then it is switched on, and produces RNA complementary to the "sense" RNA encoding a viral protein. In theory, the RNAs should bind together, blocking viral replication.

14 May 2004

Estrogen therapy may help bone density, muscle mass, sexual function, memory, and psychological wellbeing in postmenopausal women

Research in monkeys suggests that long-term use of estrogen therapy may reduce levels of androgens – hormones involved in maintaining bone density, muscle mass, sexual function, memory, and psychological wellbeing in postmenopausal women.

14 May 2004

Interacting and petting animals creates a hormonal response in humans that can help fight depression

The next time a dog comes bounding up to you for a wet, sloppy kiss and a good belly rub, don’t back away. In an ongoing study, a University of Missouri-Columbia researcher has found that interacting and petting animals creates a hormonal response in humans that can help fight depression.

14 May 2004

Signs of liver disease also improve in conjunction with alterations to gut flora

Some cirrhotic patients develop brain dysfunction, called hepatic encephalopathy, which causes deficits in behavior, intelligence, consciousness and neuromuscular function.

14 May 2004

Computed tomography solution offers more extensive views into the body with greater patient comfort

The Somatom Sensation Open, a recent development by Siemens Medical Solutions, is a computed tomography (CT) system especially designed for use in oncology and interventional CT as well as for ER examinations and bariatric patients.

14 May 2004

End-of-life options for seriously ill patients have improved considerably, but still have a ways ago

End-of-life options for seriously ill patients have improved considerably, but still have a ways ago, says a national expert who drew upon the recent experience of his father’s death to take stock of the status of end-of-life care in the United States.

14 May 2004

New Center for International Blood and Marrow Transplant Research

In their mission to improve transplant access and outcomes for patients, the National Marrow Donor Program® (NMDP) and the Medical College of Wisconsin’s International Bone Marrow Transplant Registry and Autologous Blood and Marrow Transplant Registry (IBMTR/ABMTR) have created the Center for International Blood and Marrow Transplant Research (CIBMTR.)

14 May 2004

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

The study will include a basic research component to examine the roles of B and T cells, white blood cells in the immune system, in triggering lupus symptoms.

14 May 2004

FDA approves software that determines drug dosages of insulin

The FDA has approved a software suite developed by Dimensional Dosing Systems, Inc. for determining optimum drug dosages of insulin and many other drugs as well as combinations of drugs.

14 May 2004

Largest study comparing leading hepatitis C treatments

Medical centers, hospitals, clinics and other treatment sites across the country are actively enrolling Americans with the hepatitis C virus (HCV) in a nationwide study that will for the first time determine which of the two FDA-approved pegylated interferon therapy regimens offers patients the best chance to eliminate the virus.

14 May 2004

Better understanding of radiation therapy in the treatment of breast cancer

To help patients understand the importance of radiation therapy in the treatment of breast cancer, the American Society for Therapeutic Radiology and Oncology has published the new patient information brochure Radiation Therapy for Breast Cancer: A Patient’s Guide to Understanding Treatment.

13 May 2004

Therapy News and Research

GlaxoSmithKline and Boehringer Ingelheim agree to assess the development of important HIV medicines for the developing world

Guidelines for FUZEON (enfuvirtide) are published today in AIDS

Researchers demonstrate wearable electronics to aid health and fashion

The federal government should expand its role in the financing of HIV/AIDS treatment for low-income Americans

Plans for once-daily, fixed-dose combination of three anti-HIV drugs

Higher rate of cardiac complications from smallpox vaccinations for US military

Glucose metabolism could be used to selectively destroy cancer cells

Genetically engineered viruses may create new class of cancer therapies

Risk of artery plaques increased by use of HIV drugs

3 people with drug-resistant HIV become first to undergo a new form of gene therapy

Estrogen therapy may help bone density, muscle mass, sexual function, memory, and psychological wellbeing in postmenopausal women

Interacting and petting animals creates a hormonal response in humans that can help fight depression

Signs of liver disease also improve in conjunction with alterations to gut flora

Computed tomography solution offers more extensive views into the body with greater patient comfort

End-of-life options for seriously ill patients have improved considerably, but still have a ways ago

New Center for International Blood and Marrow Transplant Research

Study of hematopoietic stem cell transplantation for severe, treatment-resistant lupus

FDA approves software that determines drug dosages of insulin

Largest study comparing leading hepatitis C treatments

Better understanding of radiation therapy in the treatment of breast cancer

Industry Focus eBook - Forensics & toxicology (2nd edition) eBook

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News